There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neuren Pharmaceuticals Limited (NURPF – Research Report) and Nanosonics Limited (NNCSF – Research Report) with bullish sentiments.
Neuren Pharmaceuticals Limited (NURPF)
In a report issued on June 30, Melissa Benson from Wilsons maintained a Buy rating on Neuren Pharmaceuticals Limited, with a price target of A$18.29. The company’s shares closed last Tuesday at $8.00.
According to TipRanks.com, Benson is a 1-star analyst with an average return of
Neuren Pharmaceuticals Limited has an analyst consensus of Moderate Buy, with a price target consensus of $11.53.
See today’s best-performing stocks on TipRanks >>
Nanosonics Limited (NNCSF)
Nanosonics Limited received a Buy rating and a A$6.00 price target from Wilsons analyst Shane Storey today. The company’s shares closed last Thursday at $3.01.
According to TipRanks.com, Storey is a 4-star analyst with an average return of
Currently, the analyst consensus on Nanosonics Limited is a Moderate Sell with an average price target of $3.16.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
